Document Classification

Section Type: RESULTS

Text: There were no other significant differences among the treatment groups with the exception of : high sensitivity C-reactive protein concentrations, which were lower in the irbesartan treatment group at day 30 (mean difference 12. 6 mg/L ; 95 % CI : -25. 1, - 0. 1 ; P = 0. 048) ; and the mean cerebral blood flow in the affected cerebral hemisphere at 30 days after stroke, which was significantly reduced by random assignment to irbesartan compared with placebo in both the affected cerebral hemisphere (-7. 5 mL/100 mL/min (95 % CI : -1. 7 to - 13. 4, P = 0. 01)) and in the unaffected hemisphere (- 7. 3 mL/100 mL/min (95 % CI : - 1. 3, -13. 4 ; P = 0. 02)).